,ID,Phenotype_name,Phenotype_category,Phenotype,Ontological_identifier
0,1,Expression_dopamine,4,Dopamine,CHEBI:18243
1,2,Expression_dopamine 1 receptor,4,Dopamine 1 receptor,NIFEXT:5845
2,3,Expression_dopamine 2 receptor,4,Dopamine 2 receptor,NIFEXT:5833
3,4,Expression_parvalbumin,4,Parvalbumin,NIFEXT:6
4,5,Expression_calbindin,4,Calbindin,NLX_MOL:1006006
5,6,Expression_calretinin,4,Calretinin,NIFEXT:5
6,7,Expression_vasopressin,4,Vasopressin,DB:00067
7,8,Expression_somatostatin,4,Somatostatin,NIFEXT:5116
8,9,Expression_nitric oxide synthase,4,Nitric oxide synthase,PR:000011326
9,10,Expression_neuropeptide Y,4,Neuropeptide Y,NIFEXT:5090
10,11,Region_dorsal striatum,1,Dorsal striatum,NLX:144489
11,12,Morphology_spiny high density,2,Spiny high density,NLX:146270
12,13,Region_substantia nigra,1,Substantia nigra,BIRNLEX:789
13,14,Expression_tyrosine hydroxylase,4,Tyrosine hydroxylase,ILX:0112125
14,15,Expression_glutamate receptor 1,4,Glutamate receptor 1,NLXMOL:20090504
15,16,Expression_glutamate receptor 1 mRNA,4,Glutamate receptor 1 mRNA,
16,17,Expression_NMDA receptor mRNA,4,NMDA receptor mRNA,NIFEXT:5250
17,18,Expression_dopamine 1 receptor mRNA,4,Dopamine 1 receptor mRNA,
18,19,Expression_dopamine 2 receptor mRNA,4,Dopamine 2 receptor mRNA,
19,20,Morphology_medium size,2,Medium size,NLX:45865
20,21,Region_striatum,1,Striatum,UBERON:0002435
21,22,Expression_choline acetyltransferase,4,Choline acetyltransferase,ILX:0102129
22,23,Expression_enkephalin mRNA,4,Enkephalin mRNA,
23,24,Expression_dynorphin mRNA,4,Dynorphin mRNA,
24,25,Expression_glutamic acid decarboxylase,4,Glutamic acid decarboxylase,NLX:203
25,26,Expression_met enkephalin,4,Met enkephalin,NLX:94955
26,27,Expression_substance p,4,Substance P,NIFEXT:5117
27,28,Morphology_small size,2,Small size,NLX:85169
28,29,Expression_pre-proenkephalin A mRNA,4,Pre-proenkephalin A mRNA,
29,30,Expression_dopamine receptor 3 mRNA,4,Dopamine receptor 3 mRNA,
30,32,Expression_vesicular monoamine transporter 2,4,Vesicular monoamine transporter-2,
31,33,Expression_phosphate activated glutaminase,4,Phosphate activated glutaminase,
32,34,Region_external globus pallidus,1,External globus pallidus,UBERON:0002476
33,35,Expression_NADPHd,4,NADPHd,
34,37,Expression_huntingtin,4,Huntingtin,
35,38,Expression_GAD67 mRNA,4,GAD67 mRNA,
36,39,Expression_parvalbumin mRNA,4,Parvalbumin mRNA,
37,40,Morphology_large size,2,Large size,NLX:10930
38,41,Expression_basic fibroblast growth factor,4,Basic fibroblast growth factor,
39,42,Expression_GABA,4,GABA,SAO:229636300
40,43,Expression_GAD65 mRNA,4,GAD65 mRNA,
41,44,Expression_glutamine synthetase,4,Glutamine synthetase,
42,45,Expression_GAD mRNA,4,GAD mRNA,
43,46,Expression_apolipoprotein D,4,Apolipoprotein D,
44,47,Expression_cannabinoid receptor 1,4,Cannabinoid receptor 1,NIFEXT:6899
45,48,Expression_GFAP,4,GFAP,
46,49,Expression_CD11b,4,CD11b,
47,50,Expression_lipocortin 1,4,Lipocortin 1,
48,51,Expression_phosphotyrosine,4,Phosphotyrosine,
49,52,Expression_S100-beta,4,S100-beta,
50,53,Expression_muscarinergic receptor 2,4,Muscarinergic receptor 2,NIFEXT:7946
51,54,Expression_kappa opioid receptor,,Kappa opioid receptor,NIFEXT:5660
52,55,Expression_PSA-NCAM,4,PSA-NCAM,
53,56,Expression_VGLUT1,4,VGLUT1,NLXMOL:1006007
54,57,Expression_pre-proenkephalin mRNA,4,Pre-proenkephalin mRNA,
55,58,Expression_pre-protachykinin mRNA,,Pre-protachykinin mRNA,
56,59,Region_striosome,1,Striosome,UBERON:0027371
57,60,Region_matrix,1,Matrix,UBERON:0027368
58,61,Expression_pre-prosomatostatin mRNA,4,Pre-prosomatostatin mRNA,
59,62,Expression_VGLUT2,4,VGLUT2,NLXMOL:1006009
60,63,Expression_VGAT,4,VGAT,
61,64,Expression_XPA,4,XPA,
62,65,Expression_XPB,4,XPB,
63,66,Expression_DARPP-32,4,DARPP-32,
64,67,Expression_enkephalin,4,Enkephalin,
65,68,Expression_glucocorticoid receptor,4,Glucocorticoid receptor,
66,69,Expression_c-fos,4,C-fos,
67,70,Expression_,4,M2 receptor / ChAT,
68,71,Electrophysiology_high frequency tonic firing,3,High frequency tonic firing,
69,73,Region_>96 micrometre from striatopallidal border,1,> 96 micrometre from striatopallidal border,
70,74,Region_<96 micrometre from striatopallidal border,1,< 96 micrometre from striatopallidal border,
71,75,Expression_VIP,4,VIP,NIFEXT:5148
72,76,Expression_cholecystokinin,4,Cholecystokinin,NIFEXT:5068
73,77,Electrophysiology_dopaminergic neuron,3,Dopaminergic neuron,
74,78,Electrophysiology_unspecified,3,,
75,79,Expression_substance P mRNA,4,Substance P mRNA,
76,80,Expression_somatostatin mRNA,4,Somatostatin mRNA,
77,81,Expression_NPY mRNA,4,Neuropeptide Y,
78,82,Expression_Nissl,4,Nissl,
79,83,Expression_S100,4,S100B,
80,84,Expression_acidic fibroblast growth factor,4,Acidic fibroblast growth factor,
81,85,Expression_NeuN,4,NeuN,
82,86,Connectivity_nigrostriatal,6,Nigrostriatal,
83,87,Expression_cAMP response element,4,cAMP response element,
84,88,Connectivity_SN,6,Substantia nigra projecting,
85,89,Connectivity_striatum,6,Striatum projecting,
86,90,Connectivity_EP,6,Entopeduncular nucleus projecting,
87,91,Connectivity_subthalamic nucleus,6,Subthalamic nucleus projecting,
88,92,Connectivity_globus pallidus,6,Globus pallidus projecting,
89,93,Region_Subthalamic nucleus,1,Subthalamic nucleus,
90,94,Connectivity_Projection neuron,6,Projection neuron,NLX:148097
91,95,"Region_Subthalamic nucleus, rostral half",1,"Subthalamic nucleus, rostral half",
92,96,"Region_Subthalamic nucleus, caudal half",1,"Subthalamic nucleus, caudal half",
93,97,"Region_Subthalamic nucleus, lateral half",1,"Subthalamic nucleus, lateral half",
94,98,"Region_Subthalamic nucleus, medial half",1,"Subthalamic nucleus, medial half",
95,99,Expression_GAD67,4,GAD67,
96,100,Expression_olig2,4,Oligodendrocyte transcription factor 2,
97,101,Expression_CD68,4,CD68,
98,102,Expression_VVA,4,Vicia Villosa Agglutinin,
99,103,Expression_GAD65,4,GAD65,
100,104,Expression_DAT,4,Dopamine transporter, ILX:0103388
101,105,Expression_5HT,4,5HT,
102,106,Expression_Iba-1,4,Iba-1,
103,107,Expression_p75,4,p75 neurotrophin receptor,
104,108,Expression_TrkA,4,TrkA,
105,109,Region_Frontal cortex,1,Frontal cortex,
106,110,Expression_pre-enkephalin,4,Pre-enkephalin,
